These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 35200560)

  • 1. Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI.
    Kovač JD; Janković A; Đikić-Rom A; Grubor N; Antić A; Dugalić V
    Curr Oncol; 2022 Jan; 29(2):698-723. PubMed ID: 35200560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
    Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
    Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
    Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
    Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahepatic mass-forming cholangiocarcinoma and solitary hypovascular liver metastases: is the differential diagnosis using diffusion-weighted MRI possible?
    Kovač JD; Galun D; Đurić-Stefanović A; Lilić G; Vasin D; Lazić L; Mašulović D; Šaranović Đ
    Acta Radiol; 2017 Dec; 58(12):1417-1426. PubMed ID: 28350257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
    Sammon J; Fischer S; Menezes R; Hosseini-Nik H; Lewis S; Taouli B; Jhaveri K
    Cancer Imaging; 2018 Feb; 18(1):8. PubMed ID: 29486800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging.
    Kim JH; Joo I; Lee JM
    Korean J Radiol; 2019 Jul; 20(7):1019-1041. PubMed ID: 31270973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI.
    Asayama Y; Nishie A; Ishigami K; Ushijima Y; Takayama Y; Fujita N; Kubo Y; Aishima S; Shirabe K; Yoshiura T; Honda H
    Diagn Interv Radiol; 2015; 21(2):96-104. PubMed ID: 25698097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A convenient scoring system to distinguish intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis based on magnetic resonance imaging features.
    Shen K; Mo W; Wang X; Shi D; Qian W; Sun J; Yu R
    Eur Radiol; 2023 Dec; 33(12):8986-8998. PubMed ID: 37392232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of Intrahepatic Cholangiocellular Carcinoma from Hepatocellular Carcinoma in the Cirrhotic Liver Using Contrast-enhanced MR Imaging.
    Wengert GJ; Baltzer PAT; Bickel H; Thurner P; Breitenseher J; Lazar M; Pones M; Peck-Radosavljevic M; Hucke F; Ba-Ssalamah A
    Acad Radiol; 2017 Dec; 24(12):1491-1500. PubMed ID: 28756085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrahepatic cholangiocarcinoma and its differential diagnosis at MRI: how radiologist should assess MR features.
    Granata V; Grassi R; Fusco R; Setola SV; Belli A; Ottaiano A; Nasti G; La Porta M; Danti G; Cappabianca S; Cutolo C; Petrillo A; Izzo F
    Radiol Med; 2021 Dec; 126(12):1584-1600. PubMed ID: 34843029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
    Tsunematsu S; Chuma M; Kamiyama T; Miyamoto N; Yabusaki S; Hatanaka K; Mitsuhashi T; Kamachi H; Yokoo H; Kakisaka T; Tsuruga Y; Orimo T; Wakayama K; Ito J; Sato F; Terashita K; Nakai M; Tsukuda Y; Sho T; Suda G; Morikawa K; Natsuizaka M; Nakanishi M; Ogawa K; Taketomi A; Matsuno Y; Sakamoto N
    Abdom Imaging; 2015 Aug; 40(6):1492-9. PubMed ID: 25579172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma.
    Viganò L; Lleo A; Muglia R; Gennaro N; Samà L; Colapietro F; Roncalli M; Aghemo A; Chiti A; Di Tommaso L; Solbiati L; Colombo M; Torzilli G
    Updates Surg; 2020 Jun; 72(2):413-421. PubMed ID: 32323164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique portal venous phase imaging discordance between CEUS and MRI: a valuable predictor of intrahepatic cholangiocarcinoma?
    Wilson SR; Burrowes DP; Merrill C; Caine BA; Gupta S; Burak KW
    Abdom Radiol (NY); 2024 Jan; 49(1):11-20. PubMed ID: 37804423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging.
    Choi SY; Kim YK; Min JH; Kang TW; Jeong WK; Ahn S; Won H
    Eur Radiol; 2018 Jun; 28(6):2549-2560. PubMed ID: 29335868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
    Kim R; Lee JM; Shin CI; Lee ES; Yoon JH; Joo I; Kim SH; Hwang I; Han JK; Choi BI
    Eur Radiol; 2016 Jun; 26(6):1808-17. PubMed ID: 26373763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI.
    Hwang J; Kim YK; Park MJ; Lee MH; Kim SH; Lee WJ; Rhim HC
    J Magn Reson Imaging; 2012 Oct; 36(4):881-9. PubMed ID: 22730271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis.
    Li R; Yuan MX; Ma KS; Li XW; Tang CL; Zhang XH; Guo DY; Yan XC
    PLoS One; 2014; 9(5):e98612. PubMed ID: 24874413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma.
    Park HJ; Kim YK; Park MJ; Lee WJ
    Abdom Imaging; 2013 Aug; 38(4):793-801. PubMed ID: 22829097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholangiocarcinoma - Part 2, Tumoral and Nontumoral Mimics and Imaging Features Helpful in Differentiation.
    Mantripragada S; Chawla A
    Curr Probl Diagn Radiol; 2022; 51(3):362-374. PubMed ID: 33627221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers.
    Xu J; Igarashi S; Sasaki M; Matsubara T; Yoneda N; Kozaka K; Ikeda H; Kim J; Yu E; Matsui O; Nakanuma Y
    Liver Int; 2012 Aug; 32(7):1156-64. PubMed ID: 22417172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.